The relationship between COVID-19 Infection and new onset and prognosis of vasospastic angina: Multi-center prospective study
Not Applicable
- Conditions
- COVID-19 infection and vasospastic angina
- Registration Number
- JPRN-UMIN000042248
- Lead Sponsor
- Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing in particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We investigate the rereshionship between the presence and absence of antibody (IgG )of COVID-19 and the following endpoints. Primary endpoints; We will compare the prevalence of COVID-19 antibody in patients with vasospasitic angina that developed before and after the COVID-19 infection epidemic.
- Secondary Outcome Measures
Name Time Method Relationship between the presence or absence of new coronavirus antibody and 5 year cardiovascular events from registration. All cause death Cardiovascular death Myocardial infarction cerebral infarction Coronary artery revascularization Hospitalization for heart failure Revascularization for peripheral arterial disease Arrhythmia attacks requiring change of treatment Deep vein thrombosis, pulmonary embolism